N-glycopeptide Signatures in Liver Diseases

ABSTRACT: (1) A N-glycopeptide method based on 18O/16O C-terminal labelling to obtain comparisons of serum from patients with HBV-related hepatocellular carcinoma (HCC-O18 labelling) and HBV-related liver cirrhosis (LC-O16 labelling) (2) MRM verification of N-glycopeptide alterations

ORGANISM(S): Homo Sapiens

SUBMITTER: Haojie Lu  

PROVIDER: PXD013586 | iProX | Tue Sep 10 00:00:00 BST 2019

REPOSITORIES: iProX